Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Agilent Technologies announced a strategic collaboration with Veeda Lifesciences to strengthen regulatory-aligned analytical and bioanalytical workflows supporting biopharma development, as GLP-1 and other complex therapeutic modalities continue to ...
read more
Vetter announced the start of construction on its new site in Saarlouis. During the first construction phase, the company will build a state-of-the-art facility for the commercial production of injectable drugs on the 95-acre industrial site.
read more
OrganaBio has acquired substantially all of the operating assets of San Diego-based Excellos Inc. to create a bicoastal cell therapy contract development and manufacturing organization.
read more
This launch is a key element of the company's broader $90 million investment plan to extend U.S.-based manufacturing capabilities, announced last year
read more
Avid Bioservices announced the appointment of Kerri McCullough Wood as Chief Commercial Officer.
read more
Ardena announced the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as Chief Commercial Officer. These additions further strengthen Ardena’s executive leadership team as the company continues to scale its operations and ...
read more
GI Partners, a private investment firm, announced it has completed the acquisition of the Contract Development and Manufacturing Organization (CDMO) and Cell Solutions businesses from Charles River Laboratories International, Inc., forming Rose ...
read more
Hovione announced that Dr. Jean Luc Herbeaux has decided to step down from his role as Chief Executive Officer for personal reasons, effective as of May 21, 2026. To facilitate a smooth transition, Dr. Herbeaux will continue with the company until ...
read more
Symeres announced the appointment of Henning Steinhagen as Chief Executive Officer, marking a key transition as the company scales its operations and broadens its market reach.
read more
Frontier Scientific Solutions announced the appointment of Michelle D’Angelo as Chief Commercial Officer (CCO).
read more
Achieve Life Sciences announced significant operational progress including the transfer of cytisinicline manufacturing to Adare Pharma Solutions. Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, ...
read more
Parexel announced the acquisition of Vitrana, a provider of an AI-enabled, end-to-end pharmacovigilance (PV) technology platform that supports patient safety and drug safety operations.
read more
Wednesday, April 29, 2026
BioDuro announced a strategic partnership with CTI Biotechnology to leverage the complementary strengths of both companies across critical stages of preclinical R&D to establish an integrated platform spanning from drug discovery to investigational ...
read more
Wednesday, April 29, 2026
LTS LOHMANN Therapie-Systeme AG announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United States at LTS' Lakewood, New Jersey facility.
read more
Paradigm Health announced the launch of a research collaboration with the FDA focused on advancing a new model to accelerate clinical trial execution and regulatory review.
read more